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Abstract 
Background: Low survival rate of transplanted cells compromises the efficacy of cell therapy. Hexokinase II (HKII) is 
known to have anti‑apoptotic activity through its interaction with mitochondria. The objective was to identify miRNAs 
targeting HKII and investigate whether miRNA‑mediated modulation of HKII could improve the survival of mesenchy‑
mal stem cells (MSCs) exposed to H2O2. The expression of HKII in MSCs exposed to H2O2 was evaluated, and HKII‑
targeting miRNA was screened based on miRNA‑target prediction databases. The effect of H2O2 on the expression of 
the selected HKII‑targeting miRNA was examined and the effect of modulation of the selected HKII‑targeting miRNA 
using anti‑miRNA on H2O2‑induced apoptosis of MSC was evaluated.
Results: H2O2 (600 μM) induced cell death of MSCs and decreased mitochondrial HKII expression. We have identified 
miR‑181a as a HKII‑targeting miRNA and H2O2 increased the expression of miR‑181a in MSCs. Delivery of anti‑miR‑
181a, which neutralizes endogenous miR‑181a, significantly attenuated H2O2‑induced decrease of HKII expression and 
disruption of mitochondrial membrane potential, improving the survival of MSCs exposed to H2O2.
Conclusions: These findings suggest that H2O2‑induced up‑regulation of miR‑181a contributes to the cell death of 
MSCs by down‑regulating HKII. Neutralizing miR‑181a can be an effective way to prime MSCs for transplantation into 
ischemic tissues.
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Background
For many decades, ischemic heart diseases such as myo-
cardial infarction (MI) have been a leading cause of death 
worldwide [1]. Cell therapy using various stem cells is 
one of the therapeutic approaches to manage such heart 
disease [2]. However, high death rate of the transplanted 
cells has hampered the efficacy of stem cell-based cell 
therapy [3]. One of the major reasons for such low sur-
vival of transplanted cells is that the transplanted cells are 
also immediately exposed to a harsh microenvironment 
(i.e., low tissue oxygen and nutrients, and increased 
reactive oxygen species (ROS) in case of ischemic heart 
disease), which can induce various types of cell death, 
including apoptosis [4]. Consequently, discovery of alter-
native means to attenuate or prevent the onset of apop-
tosis of transplanted cells is of utmost importance for 
developing effective therapeutic strategy.
One of the molecules known to play an important role 
in preventing apoptosis is hexokinase II (HKII) [5]. HK 
family is composed of four different isotypes (1 to 4, or I 
to IV) and they can initiate the glycolysis pathway where 
glucose is converted to glucose-6-phosphate [6]. Addi-
tionally, HKs are known to have non-enzymatic activi-
ties such as anti-apoptotic activity [7]. A previous study 
reported that myocardial ischemia/reperfusion (I/R) 
injury decreased the cardiac expression of HKII as well 
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as the binding to mitochondria, and it was associated 
with decreased cardiac function [8]. Thus, assuming the 
cell death mechanisms of transplanted cells are similar 
to those of host cells, maintaining the expression of HKII 
may improve the survival of transplanted cells. Regard-
ing the regulation of HKII expression, we speculate that 
microRNAs (miRNA or miR) may be involved. MicroR-
NAs are approximately 22-nucleotide-long RNAs that 
attenuate certain gene expression by either inhibiting 
mRNA translation or degrading mRNAs [9], and studies 
have demonstrated that miRNAs, such as miR-143 and 
miR-125a-5p, negatively regulated HKII expression in 
cancer cells [10–12]. This prompted us to examine possi-
ble involvement of HKII-targeting microRNAs (miRNAs) 
in the death of transplanted cells.
In the present study, we examined the possibility of 
miRNA-dependent HKII regulation during ROS-induced 
death of mesenchymal stem cells (MSCs). We identified 
miR-181a as a HKII-targeting miRNA and demonstrated 
that its expression increased during ROS-induced apop-
tosis of MSCs. We further examined the potential of anti-
miR-181a as an anti-apoptotic agent for MSCs exposed 
to ROS in vitro.
Results
H2O2 induced cell death of MSCs and decrease 
of mitochondrial HKII expression
H2O2, which has been used to induce apoptosis of MSCs 
[13], was used to simulate oxidative stress after trans-
plantation. H2O2 concentration-dependently decreased 
cell viability of MSCs, and 600  μM or higher concen-
trations of H2O2 significantly decreased cell viability 
of MSCs after 6  h of treatment (Fig.  1a). Since 6  h of 
treatment with 600 μM of H2O2 significantly induced cell 
death of MSCs, this particular condition was use for fur-
ther experiments. For the expression of HKII, H2O2 time-
dependently decreased HKII in mitochondrial fraction, 
while it had no significant effect on HKII in cytosolic 
fraction (Fig.  1b), suggesting the decrease of mitochon-
drial HKII contributed to cell death of MSCs exposed to 
H2O2.
Identification of HKII targeting miRNA and its expression 
during H2O2‑induced cell death
To screen miRNAs targeting HKII, miRNA-target pro-
tein prediction databases (http://www.targetscan.org 
and http://www.umm.uni-heidelberg.de/apps/zmf/
mirwalk/) were utilized. The TargetScan database pre-
dicted 23 miRNAs families broadly conserved among 
vertebrates. In case of the miRWalk database, it pro-
vided comparative analysis by 8 prediction programs 
and the number of miRNAs predicted by more than 3 
prediction programs was 25. Among these miRNAs, 6 
miRNAs were shared by the two groups (Fig.  2a). We 
transfected MSCs with those 6 miRNAs and examined 
the expression of HKII. Among these 6 miRNAs, miR-
181a significantly decreased the expression of HKII in 
MSCs (Fig. 2b). To examine whether miR-181a directly 
targets HKII, we also conducted a luciferase assay. The 
luciferase assay used in the present study is to evaluate 
the effect of miRNA-dependent post-transcriptional 
regulation of target genes [14]. In this luciferase assay, 
3′UTR of HKII was cloned into a plasmid containing the 
gene codes for luciferase. Since the 3′UTR of HKII was 
positioned immediately after the luciferase gene in the 
constructed plasmids, if miRNA effectively recognize 
Fig. 1 Decrease of mitochondrial HKII during H2O2‑induced MSC cell death. MSCs were exposed to increasing concentrations of H2O2 simulat‑
ing ROS for 6 h. a Cell viability of MSCs exposed to varying concentrations of H2O2. *p < 0.05 compared to Control. b Time dependent changes of 
mitochondrial and cytosolic expressions of HKII in MSCs exposed to H2O2. **p < 0.05 compared to Control. The quantitative data were expressed as 
the mean ± s.e.m of at least three independent experiments.
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and target the 3′UTR of HKII, the translation of lucif-
erase is also affected and the expression of luciferase is 
suppressed. The result of the luciferase assay indicated 
that miR-181a transfection decreased the expression of 
luciferase linked to the 3′UTR of HKII (pmirGLO-HKII 
3′UTR), while the luciferase expression of the cells trans-
fected with control luciferase vector lacking the 3′UTR 
of HKII (pmirGLO) was not affected by miR-181a trans-
fection. This indicated that miR-181a directly targeted 
the 3′UTR of HKII (Fig.  2c). To examine the possible 
relationship between oxidative stress and miR-181a, the 
expression of miR-181a in MSCs treated with H2O2 was 
evaluated. According to the real time PCR data, H2O2 
significantly up-regulated the expression of miR-181a in 
a time-dependent manner (Fig. 2d).
Neutralization of miR‑181a attenuates cell death of MSCs 
induced by H2O2
Since we speculate that H2O2-induced up-regulation of 
miR-181a contributed to the down-regulation of mito-
chondrial HKII expression, we neutralized endogenous 
miR-181a using anti-miR-181a and examined its effect 
on mitochondrial HKII expression. Without H2O2 treat-
ment, anti-miR-1861a transfection had no significant 
effect on mitochondrial HKII expression. However, with 
H2O2 treatment, anti-miR-181a attenuated mitochondrial 
HKII expression compared to H2O2 only treated group 
(Fig. 3a). This suggested that miR-181a-dependent regu-
lation of HKII may be negligible under normal (with-
out H2O2) condition. For the effect of anti-miR-181a on 
the survival of MSCs exposed to H2O2, H2O2-induced 
decrease of MSC survival was further decreased by miR-
181a treatment, while anti-miR-181a treatment reversed 
such decrease (Fig. 3b), indicating suppression of H2O2-
induced increase of miR-181a may be an effective way to 
enhance cell survival. Furthermore, H2O2 induced sig-
nificant accumulation of tetramethylrhodamine methyl 
esters (TMRM) in the inner membrane of mitochondria 
indicating loss of mitochondrial membrane potential. 
However, such increase of TMRM accumulation was 
attenuated by anti-miR-181a transfection prior to H2O2 
treatment suggesting that anti-miR-181a suppressed 
H2O2-induced mitochondrial membrane potential loss 
(Fig. 3c).
Discussion
One of the major problems of cell therapy is low survival 
rate of transplanted cells. Thus developing an effective 
strategy to enhance the survival of the transplanted cells 
is of importance. Here, we report that miRNA-depend-
ent modulation of HKII improves the survival of MSCs 
exposed to ROS.
Fig. 2 MicroRNA‑181a targets HKII and increased by H2O2. a Candidate HKII‑targeting miRNAs were selected based on miRNA‑target prediction 
databases (TargetScan and miRWalk). b Effect of six candidate miRNAs on the expression of HKII was examined by western blot. *p < 0.05 compared 
to Control. c Luciferase assay using 3′UTR of HKII was performed to confirm the interaction between miR‑181a and HKII. *p < 0.05 compared to 
Control [miR (−)]. NC negative control miRNA. d Time dependent expression changes of miR‑181 in MSCs exposed to H2O2. *p < 0.05 compared to 
Control. The quantitative data were expressed as the mean ± s.e.m of at least three independent experiments.
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The anti-apoptotic activity of HKII is based on their 
interaction with mitochondria [15, 16]. HKII, having 
the hydrophobic mitochondrial binding domain in their 
N-terminus [16, 17], can bind to mitochondria in associ-
ation with the voltage-dependent anion channel (VDAC) 
[18], constituting the mitochondria permeability transi-
tion pore (PT-pore) [19]. This mitochondrial localization 
of HKII maintains mitochondrial integrity and prevent 
bcl-2 homologous antagonist killer (BAK) and bcl-2 
associated protein X (BAX) mediated mitochondrial 
cytochrome c release and subsequent apoptosis [20, 21]. 
Our data also suggested that ROS-induced cell death via 
dissociation of HKII from mitochondria in our experi-
mental settings.
H2O2-induced up-regulation of miR-181a has been 
also reported in rat cardiomyocytes [22]. That particular 
study clearly demonstrated that H2O2-induced up-regu-
lation of miR-181a significantly contributed to apoptosis 
of cardiomyocytes. Thus, our premise that the cell death 
mechanisms of transplanted cells may be similar to those 
of host cells was supported. Although the above men-
tioned study did not examined the relationship between 
the up-regulation of miR-181a and HKII expression, it 
is possible that miR-181a-mediated down-regulation of 
HKII also contributed to the observed cell death of car-
diomyocytes in that previous study.
To date, only few miRNAs that regulate HKII have been 
identified in mostly cancer cells. For example, miR-143 
has been reported to down-regulate HKII in colon cancer 
cells, reducing cell proliferation [11]. Other studies also 
have demonstrated that miR-143 significantly increased 
the number of apoptotic cells compared to control in 
cancer cells [10, 12], suggesting down-regulation of HKII 
significantly contributes to progression of apoptosis. On 
the other hand, miR-143 repressive miR-155 led to up-
regulation of HKII and promoted breast cancer cell pro-
liferation [23]. These observations together suggest that 
miRNA-mediated regulation of HKII does occur, and 
modulation of HKII-targeting miRNAs to control cell 
survival is a feasible therapeutic approach.
Fig. 3 Anti‑miR‑181a attenuates HKII expression and H2O2‑induced cell death of MSCs. a Effect of anti‑miR‑181a on HKII expression was examined 
by western blot. *p < 0.05. b Effect of anti‑miR‑181a on the survival of MSCs exposed to H2O2 was evaluated. *p < 0.05 compared to untreated 
control. #p < 0.05 compared to H2O2 only treated group. c Effect of anti‑miR‑181a on H2O2‑induced mitochondrial membrane potential disturbance 
was examined by using cytometry with TMRM. *p < 0.05 compared to untreated control. **p < 0.05 compared to H2O2 only treated group. The 
quantitative data were expressed as the mean ± s.e.m of at least three independent experiments.
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The approach used in the present study was not 
intended to increase the mitochondrial binding effi-
cacy of HKII, but to attenuate H2O2-induced increase 
of miR-181a and subsequent decrease of HKII expres-
sion. Although our data indicate that this approach works 
in vitro, it should be further validated in vivo as well with 
optimized delivery method of anti-miR-181a. Although 
MSCs were primed by anti-miR-181a treatment before 
exposed to H2O2 in this study, simultaneous delivery of 
primed MSCs and anti-miR-181a to damaged heart can 
be therapeutically more effective because anti-miR-181a 
delivery to damaged heart may enhance the survival of 
host cardiomyocytes on the verge of activation of apop-
totic signaling as well. Another limitation of this study is 
lacking information about the effect of miR-181a modu-
lation on the differentiation potential of MSCs. Since this 
study was focused on testing the feasibility of enhancing 
MSC survival by modulating key miRNA and its target, 
we have not examined the effect of anti-miR-181a on the 
differentiation of MSCs. Since previous studies have indi-
cated that miR-181a accelerated endothelial cell [24] and 
adipocyte [25] differentiation of embryonic stem cells and 
pre-adipocyte, respectively, it can be speculated that sup-
pressing miR-181a may alter the differentiation potential 
of MSCs as well. Nevertheless, it should be empirically 
proved, and examining such possibility in further studies 
will help us to develop improved regenerative therapeutic 
strategies involving MSC-based cell therapy.
Conclusions
In summary, we demonstrate that anti-miR-181a attenu-
ates cell death of MSCs exposed to H2O2 through sup-
pression of miR-181a and subsequent down-regulation of 
HKII. With further optimization of delivery strategy and 
in vivo validation, anti-miR-181a can be an effective ther-
apeutic agent for improving the survival of transplanted 
cells in cell therapy, and the result of this study warrants 




Four-week-old Sprague–Dawley rats were used for MSC 
isolation. The rats were anesthetized with zoletil (20 mg/
kg) and xylazine (5 mg/kg). All animal experimental pro-
cedures were approved by the Institutional Animal Care 
and Use Committee (IACUC) of Yonsei University Col-
lege of Medicine and performed in accordance with the 
Guidelines and Regulations for Animal Care.
Isolation and culture of rat MSCs
Bone marrow-derived MSCs were isolated and collected 
from aspirates of rat femurs and tibias with 10  mL of 
MSC medium consisting of Dulbecco’s modified Eagle’s 
medium (DMEM)-low glucose supplemented with 10 % 
fetal bovine serum (FBS) (Invitrogen) and 1  % antibi-
otic-penicillin and streptomycin. Mononuclear cells 
recovered from the interface of Ficoll-Paque PLUS (GE 
healthcare)-separated bone marrow were washed twice 
and resuspended in DMEM with 10 % FBS, then plated 
at a density of 1 ×  106 cells/100  mm dish. The cultures 
were maintained at 37  °C in a humidified atmosphere 
containing 5  % CO2. After 72  h, the non-adherent cells 
were discarded, and the adherent cells were thoroughly 
washed twice with phosphate-buffered saline (PBS). 
Fresh MesenPRO RS™ Medium (Invitrogen) was added 
and then replaced every 3 days for approximately 10 days 
to achieve stable multi-potentiality.
H2O2 treatment
The cells were cultured for 24 h before the experiments. 
For inducing apoptosis, H2O2 was added to the culture 
media at a final concentration of 500–800 μM for 6 h.
Cell viability assay
To measure cell viability, CCK reagent (cell counting kit-
8, Dojindo) was added to each well for a final concentra-
tion of 0.5 mg/mL and the cells were incubated at 37 °C 
for 2 h. The absorbance of the medium was measured at 
450 nm using a microplate reader.
Transfection of miRNA and anti‑miRNA
Transfections of miRNA mimics and anti-miRNAs were 
performed using siLentFect™ Lipid reagent (Life Sci-
ence Research). Mature specific miRNAs (Genolution 
Pharmaceuticals, Inc., Korea) were used at a final con-
centration of 100 nM. Anti-miRNAs was used at a final 
concentration of 50 nM. After 4 h of incubation in a CO2 
incubator at 37 °C, the medium was changed to 10 % FBS 
containing DMEM.
Western blot
Cells were washed once in PBS and lysed in lysis buffer 
(Cell Signaling Technology) with protease and phos-
phatase inhibitor cocktail. Protein concentrations were 
determined using the BCA protein assay kit (Thermo Sci-
ence). Proteins were separated in a SDS–polyacrylamide 
gel and transferred to the PVDF membrane (Millipore). 
After blocking the membrane with 0.1  % Tris-buffered 
saline–Tween 20 (TBS-T, 0.1  % Tween 20) containing 
10 % skim milk for 1 h at room temperature, the mem-
brane was washed twice with TBS and incubated with 
primary antibodies for overnight at 4 °C. The membrane 
was washed three times with 0.1  %TBS-T for 5  min 
and then incubated for 1  h at room temperature with 
horseradish peroxidase (HRP)-conjugated secondary 
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antibodies. After extensive washing, the bands were 
detected by enhanced chemiluminescence reagent (ECL, 
Santa Cruz Biotechnology). The band intensities were 
quantified using NIH Image J version 1.34e software. The 
primary antibodies for HKII and β-actin were from Cell 
Signaling (28675) and Sigma (A1978), respectively.
Luciferase assay using the 3′UTR of HKII
The 3′UTR sequences of HKII was amplified using prim-
ers with XbaI (forward) and EcoRI (reverse) endonucle-
ase sites. The 3′UTR fragment was then cloned into the 
pmirGLO vector. HeLa cells were plated at a density of 
1 × 105 cell/well in a 12 well plate, and then transfected 
with either pmirGLO control vector or pmirGLO vector 
with HKII 3′UTR using Lipofectamine 2000. After 48 h, 
relative luciferase activity was measured by using Dual 
Luciferase assay kit (Promega) according to the manufac-
turer’s instructions. The Renilla luciferase was used for 
normalization.
Real‑time PCR
Purified total RNA (100  ng) was used for reverse tran-
scription (TaqMan® MicroRNA Reverse Transcriptase 
Kit, Applied Biosystems) in combination with TaqMan® 
MicroRNA assays to quantify the levels of each specific 
miRNA according to the manufacturer’s instructions. The 
amplification and detection of specific products were per-
formed using a TaqMan Small RNA Assay kit (AB Applied 
Biosystems) at 95 °C for 10 min, followed by 40 cycles of 
95 °C for 15 s and 60 °C for 60 s. The threshold cycle (Ct) 
of each target gene was defined automatically; the Ct 
value was located in the linear amplification phase of the 
PCR and was normalized to the Ct value of the control 
transcript U6 (ΔCt value). The relative expression level of 
each miRNA was calculated using the ΔΔCt method and 
is reported as the fold-change in expression (2-ΔΔCt).
Tetramethylrhodamine methyl ester (TMRM) staining
Mitochondrial membrane potential was determined by 
using tetramethylrhodamine methyl esters (TMRM) 
fluorescent dye (Invitrogen) [26]. Loss of mitochondrial 
membrane potential triggers the accumulation of cati-
onic dye (TMRM) in the mitochondria. To evaluate mito-
chondrial membrane permeability, the cells were loaded 
with 200 nM of TMRM for 30 min at 37 °C in medium. 
Then, the cell pellets were washed with pre-warmed with 
PBS and re-suspended with PBS to analyze. The data 
were performed by BD ACCURI C6 cytometer (BD Bio-
sciences) and analyzed with BD Accuri C6 Software.
Statistical analysis
Quantitative data were expressed as the mean ±  S.E.M 
(standard error of measurement) of at least 3 independent 
experiments. For statistical analysis, one-way ANOVA 
with Bonferroni correction was performed using the 
OriginPro 8 SR4 software (ver. 8.0951, OriginLab Corpo-
ration, Northampton, MA, USA). A p value of less than 
0.05 was considered to be statistically significant.
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